Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention
Article in Atherosclerosis (February 2024)
The most recent citing publications are shown below. View all 126 publications that cite this research output on Dimensions.
Article in Atherosclerosis (February 2024)
Book chapter (January 2024)
Book chapter (January 2024)